Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000313149 | SCV000380183 | uncertain significance | Glucocorticoid deficiency with achalasia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004955412 | SCV005484734 | uncertain significance | Inborn genetic diseases | 2024-12-10 | criteria provided, single submitter | clinical testing | The c.65A>G (p.N22S) alteration is located in exon 1 (coding exon 1) of the AAAS gene. This alteration results from a A to G substitution at nucleotide position 65, causing the asparagine (N) at amino acid position 22 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |